Here, we describe the case of a patient diagnosed with a grade 2 IDH‐mutant 1p19q‐codeleted oligodendroglioma, with persistent seizures after surgery, who received vorasidenib alone and achieved early seizure freedom coupled with a metabolic PET response. Here, IDH1 is linked to oligodendroglioma.